JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
QUICK SEARCH:   [advanced]


     

Anesth Analg 1988; 67:430-434
© 1988 International Anesthesia Research Society
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Strömskag, K. E.
Right arrow Articles by Ogenstad, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Strömskag, K. E.
Right arrow Articles by Ogenstad, S.

Intrapleural Administration of 0.25%, 0.375%, and 0.5% Bupivacaine with Epinephrine after Cholecystectomy

Kjell Erik Strömskag, MD, Finn Reiestad, MD, Ewa L. O. Holmqvist, CRNA, and Stephan Ogenstad, PhD

The Department of Anesthesia, Molde County Hospital, Norway, the Pain Control, Clinical Research, and Department of Biostatistics, Astra, Sweden.

Abstract

Thirty patients who had undergone Cholecystectomy (subcostal incision) were randomly allocated to three groups of ten patients each and given intrapleural injections of 20 ml 0.25% (group I), 0.375% (group II), or 0.5% (group III) bupivacaine each with added epinephrine (5 µg/ml). Complete pain relief was obtained within 30 minutes in all but one patient in groups 1 and II. Pain scores (VAS, 0–100 mm) were recorded at regular intervals and did not exceed 20 mm (mean) in any group from 30 minutes up to 4 hours.

Median time interval from the intrapleural injection to administration of supplementary analgesics was 4 hours 20 minutes, 6 hours, and 7 hours 45 minutes in groups I, II, and III, respectively. The maximum plasma concentration of bupivacaine (Cmax), 0.62 (± 0.25 SD) µg/ml in group I, 0.82 (± 0.40) µg/rnl in group II, and 1.20 (± 0.44) µg/ml in group III, was significantly higher in group III than in the other groups. The time to achieve maximum plasma concentration of bupivacaine (Tmax) was approximately 15 minutes in all groups. No side effects were observed.

Key Words: ANESTHETIC TECHNIQUES—interpieural catheter technique. • ANESTHETICS, LOCAL—bupivacaine. • PAIN—postoperative.




This article has been cited by other articles:


Home page
 SEMIN CARDIOTHORAC VASC ANESTHHome page
D. M. Gratch and R. McMurtrie
Pain Management in Chest Trauma
Seminars in Cardiothoracic and Vascular Anesthesia, June 1, 2002; 6(2): 113 - 125.
[Abstract] [PDF]

Home page
 Anesth. Analg.Home page
R. Greif, T. Wasinger, K. Reiter, M. Chwala, and J. Neumark
Pleural Bupivacaine for Pain Treatment After Nephrectomy
Anesth. Analg., August 1, 1999; 89(2): 440 - 440.
[Abstract] [Full Text] [PDF]

Home page
 J Intensive Care MedHome page
D. S. Stevens and W. T. Edwards
Management of Pain in the Critically Ill
J Intensive Care Med, November 1, 1990; 5(6): 258 - 291.
[Abstract] [PDF]

Home page
 Arch SurgHome page
M. A. El-Naggar, F. J. Schaberg Jr, and M. R. Phillips
Intrapleural Regional Analgesia for Pain Management in Cholecystectomy
Arch Surg, May 1, 1989; 124(5): 568 - 570.
[Abstract] [PDF]


Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 1988 by the International Anesthesia Research Society.